Active Stocks

Fri Apr 10 2026 15:59:05

Kotak Mahindra Bank share price
374.75 0.75%

Tata Steel share price
206.60 0.66%

ITC share price
304.20 0.40%

Eternal share price
240.25 0.99%

HDFC Bank share price
810.40 1.65%

Business News > Mint Authors > Isha Trivedi

Isha Trivedi

ARTICLES BY ISHA TRIVEDI

Ginni Rometty, chairperson, president and CEO of IBM, remains optimistic about India’s growth story because of good progress of some of the key government programmes, a talented work force and government’s push towards ease of doing business. File photo: PTI

IBM chief Ginni Rometty puts emphasis on responsible use of data

2 min read . 14 Feb 2018

Etanercept will be the Lupin’s first biosimilar product for the global market.

Lupin to file application for biosimilar etanercept in EU, Japan in next quarter

1 min read . 08 Feb 2018

On Monday, shares of Biocon ended up 1.23% at Rs614.80 on the BSE, while benchmark Sensex index closed up 0.65% at 36,283.25 points. Photo: Mint

EU committee recommends approval of Biocon-Mylan’s insulin glargine

1 min read . 29 Jan 2018

In a report dated 4 January, brokerage firm CLSA said consolidation will gather steam in 2018 for the pharma sector globally. Photo: Bloomberg

Pharma firms to tap M&A opportunities to gain scale, tide over challenges

3 min read . 26 Jan 2018

Biocon chairperson and managing director Kiran Mazumdar-Shaw. On Wednesday, Biocon shares fell 1.1% to Rs634.60 on BSE while Sensex gained 0.1% to 36,161.64 points. Photo: Hemant Mishra/Mint

Biocon profit down 46% to Rs91.9 crore in December quarter

1 min read . 25 Jan 2018

The 8-18% reduction in overall angioplasty procedure cost is for patients undergoing single vessel procedure, which forms around 70% of the total number of patients undergoing angioplasty. Photo: Reuters

Angioplasty costs down 8-18% post stent price cut, says study

3 min read . 25 Jan 2018

(From left) Larry Paulson, president of Qualcomm India; Mohanbir Sawhney, professor at Kellogg School of Management; Haresh Chawla, partner at True North; and Ananda Mukerji, executive chairman of Anunta Tech, at SBAC2018 in Mumbai.

Companies need will and commitment to drive innovation

3 min read . 22 Jan 2018

Lupin pointed out that 47 new generic drug manufacturers entered the US market in 2017 and regulatory approvals for generic drugs have also increased. Photo: Bloomberg

Lupin sees high single-digit price erosion in generic drugs in US this year

2 min read . 10 Jan 2018

During 2019-21, Aurobindo Pharma plans to ramp up filing of specialty drugs and differentiated products, launch the first set of cancer, respiratory and topical products and complex injectables in the US and launch biosimilars and vaccines in the emerging markets. Photo: Bloomberg

Aurobindo Pharma to diversify product portfolio to propel future growth

2 min read . 09 Jan 2018

Pharma firms have for long enjoyed strong growth but over the last 2-3 years, earnings have declined because of pricing pressure in the US. Photo: HT

Drug makers pare costs as profitability continues to fall

2 min read . 29 Dec 2017

So far in 2017, shares of Dr. Reddy’s have plunged 22%, while the benchmark Sensex has gained 26%. Photo: Mint

Dr. Reddy’s growth prospects brighten as regulatory concerns subside

3 min read . 20 Dec 2017

On Thursday, shares of Glenmark ended up 0.25% at Rs533.40 on the BSE, while the benchmark Sensex index was up 0.59% at 33,246.70 points.

Glenmark to file first specialty product with US FDA in March quarter

2 min read . 14 Dec 2017

The company expects to clock a revenue of Rs400 crore in the current financial year.

Cloudnine to open 10 hospitals over next 2 years

1 min read . 13 Dec 2017

Mumbai-based USV Pvt. Ltd has two other biosimilars in pipeline but they haven’t yet reached the clinical studies stage. Photo: Hemant Misra/Mint

EU regulator accepts USV’s application for biosimilar pegfilgrastim

1 min read . 07 Dec 2017

At 10.31am, shares were trading up 9.20% at Rs487.65 on the BSE, while benchmark Sensex index was up 0.3% at 32,930.18 points. Photo: Hemant Mishra/Mint

Biocon shares ends 15% higher on USFDA approval for Herceptin biosimilar

1 min read . 04 Dec 2017

In 2015, Glenmark had entered into a strategic development and licensing agreement with Celon Pharma SA to develop and market a generic version of Seretide Accuhaler.

Glenmark gets approval for generic Seretide inhaler in Nordic region

1 min read . 02 Dec 2017

Mylan and Biocon are exclusive partners on a broad portfolio of biosimilar and insulin products. Photo: Hemant Mishra/Mint

US FDA approves Mylan-Biocon’s biosimilar for cancer drug Herceptin

2 min read . 02 Dec 2017

Glenn Saldanha, chairman and CEO of Glenmark Pharmaceuticals Ltd. Shares of Glenmark closed 3.3% down at Rs571.80 on BSE, while benchmark Sensex index ended at 33,618.59 points, down 0.3% from Monday’s close. Photo: Reuters

Glenmark shares fall 3.3% after US FDA warnings about Baddi plant

1 min read . 29 Nov 2017

Dilip Shanghvi, chairman and managing director of Sun Pharma. The company reported US sales of $309 million in the September quarter, the lowest in the last 18 quarters. Photo: HT

Sun Pharma hoping recovery in US in second half, street wary

2 min read . 25 Nov 2017

It is also important for the government to ensure that a liberal law does not lead to more sex-selective abortions. Illustration: Jayachandran/Mint

Is just changing the law on abortions enough?

6 min read . 24 Nov 2017